Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (1.445)

1

Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer : Patient-reported outcomes in ECOG-ACRIN EA1131

enthalten in: Cancer | 2024

von Smith, K. | Zhao, F. | Mayer, I. | +22

2

Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC : exploratory analysis from KEYNOTE-522

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Pusztai, L. | Denkert, C. | O'Shaughnessy, J. | +16

3

Evaluating the heterogeneity of hippocampal avoidant whole brain radiotherapy treatment effect : A secondary analysis of NRG CC001

enthalten in: Neuro-oncology | 2024

von Cherng, H. | Sun, K. | Bentzen, S. | +5

4

A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML

enthalten in: Leukemia | 2024

von Garcia-Manero, G. | Podoltsev, N. | Othus, M. | +23

5

DELIVER : A Safety Study of a Dapivirine Vaginal Ring and Oral PrEP for the Prevention of HIV During Pregnancy

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2024

von Bunge, K. | Balkus, J. | Fairlie, L. | +11

6

OCT Grading System of Macular Infarction Predicts Vision in Participants With Central Retinal or Hemiretinal Vein Occlusion : A Secondary Analysis of SCORE2

enthalten in: American journal of ophthalmology | 2023

von Au, A. | Ip, M. | Blodi, B. | +4

7

Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women : a secondary analysis of the HPTN 083 trial

enthalten in: The lancet. HIV | 2023

von Marzinke, M. | Hanscom, B. | Wang, Z. | +71

CommentIn: Lancet HIV. 2023 Nov;10(11):e694-e695. - PMID 37783220

8

DHA, nutrient intake, and maternal characteristics as predictors of pregnancy outcomes in a randomised clinical trial of DHA supplementation

enthalten in: Clinical nutrition (Edinburgh, Scotland) | 2023

von Wang, Y. | Gajewski, B. | Valentine, C. | +5

9

Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials

enthalten in: Nature communications | 2023

von Rediti, M. | Fernandez-Martinez, A. | Venet, D. | +19

10

Viral Resistance Analyses From the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1)

enthalten in: The Journal of infectious diseases | 2023

von Hedskog, C. | Rodriguez, L. | Roychoudhury, P. | +11

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[145]